Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 3Terminated 2Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 18Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Stomach Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Adenocarcinoma 2Lung Neoplasms 2Inflammatory Breast Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Solid Cancer 1Sarcoma 1Oropharyngeal Neoplasms 1Non-Small Cell Lung Cancer Metastatic 1Non Small Cell Lung Cancer NSCLC 1Neoplasms 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy 1Lip Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Laryngeal Neoplasms 1Kidney Neoplasms 1Invasive Breast Cancer 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1

Interventions

Cisplatin 10pembrolizumab 8Carboplatin 8Paclitaxel 6durvalumab 5Pemetrexed 51-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 5osimertinib 4Specimen Handling 4Magnetic Resonance Spectroscopy 4Taxes 3Nivolumab 3Gemcitabine 3Docetaxel 3Bevacizumab 3cabozantinib 2atezolizumab 2Sunitinib 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiation 2Platinum 2Immunoglobulin G 2Disulfides 2CP protocol 2Biopsy 21,2-diaminocyclohexaneplatinum II citrate 2trifluridine tipiracil drug combination 1tremelimumab 1relatlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma × Albumin-Bound Paclitaxel × Clear all
NCT04879368 2025-07-17

INTEGRATEIIb

Australasian Gastro-Intestinal Trials Group

Phase 3 Active not recruiting
450 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡